For the year ending 2025-12-31, PMN has $9,182,421 in assets. $10,441,013 in debts. $6,116,556 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash | 6,116,556 | |||
| Short-term investments | 33,753 | |||
| Prepaid expenses and other current assets | 3,032,112 | |||
| Total current assets | 9,182,421 | |||
| Total assets | 9,182,421 | |||
| Accounts payable | 2,543,415 | |||
| Accrued liabilities | 7,868,416 | |||
| Total current liabilities | 10,411,831 | |||
| Share-based compensation liability | 29,182 | |||
| Total liabilities | 10,441,013 | |||
| Additional paid-in capital | 129,518,812 | |||
| Accumulated other comprehensive loss | -371,184 | |||
| Accumulated deficit | -130,406,220 | |||
| Total shareholders' (deficit) equity | -1,258,592 | |||
| Total liabilities and shareholders' (deficit) equity | 9,182,421 | |||
ProMIS Neurosciences Inc. (PMN)
ProMIS Neurosciences Inc. (PMN)